RENOVORX, INC.

RNXT ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024
Revenue $1.1M $43.0K
Cost of Revenue $327.0K $0
Gross Profit $796.0K $43.0K
Gross Margin 70.9% 100.0%
Operating Expenses
Research & Development $6.3M $6.0M
SG&A Expense $7.0M $5.0M
Operating Income $-12.5M $-11.0M
Operating Margin -1,114.0% -25,511.6%
Interest Expense
Pretax Income $-11.2M $-8.8M
Income Tax Expense $2.0K
Net Income $-11.2M $-8.8M
Net Margin -994.5% -20,497.7%
EPS (Basic) $-0.32 $-0.40
EPS (Diluted) $-0.32 $-0.40
Shares Outstanding (Basic) 35.3M 22.3M
Shares Outstanding (Diluted) 35.3M 22.3M
Dividends Per Share